The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

Summary

The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.

Timeline

Start

2009-11

Primary completion

2011-12

Completion

2011-12

Outcome

Met primary endpoint

paper Efinaconazole 10% nail solution was superior to vehicle for all primary and secondary outcome measures assessed. PMID 25007364 ↗

Publications

• Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials. J Drugs Dermatol. 2014 Jul;13(7):815-20.

Drugs

Indications